Toggle Menu
Shorted
most shorted
screener
strategies
housing
economy
industry intel
More
⌘K
Toggle theme
Stocks
SUD
Company
SUD
Suda Pharmaceuticals
Short interest
<0.01%
–
0.00 pp 30d
as of 25 June 2021
Reported shorts
3.8K
Shares on issue
384.656M
Overview
Short interest
Strategy
Financials
Company
News
Community
Suda Pharmaceuticals (SUD) company profile
Profile, insiders and operations
Director trades
20 trades recorded
Date
Director
Type
Shares
Price
Value
2026-06-10
Unknown Director
buy
-
-
-
2026-06-09
David John Williams
buy
200,000
$0.067
$13,400
2025-11-25
Unknown Director
buy
-
-
-
2025-11-24
Elizabeth Stoner
exercise options
1,157,647
$0.047
$54,663.53
2025-11-13
Unknown Director
buy
-
-
-
2025-11-12
Debora Barton
exercise options
1,013,333
-
-
2025-11-11
Unknown Director
buy
-
-
-
2025-11-10
Michael Baker
exercise options
2,991,266
-
-
2025-10-15
Unknown Director
buy
-
-
-
2025-10-13
Michael Baker
exercise options
1,617,021
-
-
2024-11-29
Unknown Director
buy
-
-
-
2024-11-26
Debora Barton
exercise options
974,000
-
-
2024-04-03
Unknown Director
buy
-
-
-
2024-04-02
Unknown Director
buy
-
-
-
2024-03-28
Gary Phillips
buy
66,666
$10000.000
$666,660,000
2024-03-28
Dr Thomas Duthy
buy
103,000
$14935.000
$1,538,305,000
2024-03-28
Unknown Director
buy
-
-
-
2024-03-27
Michael Baker
buy
220,000
$0.142
$31,289.96
2024-01-02
Unknown Director
buy
-
-
-
2023-12-29
Michael Baker
exercise options
587,824
-
-
SUD intelligence dossier
Public-source evidence for this company, with industry drill-up links.
Tax paid and taxable income records
Government contracts and public money
Emissions and trade exposure
Political donations and lobbying links
Sign in to unlock the dossier
Free account · no card required